• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬缺血40分钟及再灌注4天后,超氧化物歧化酶未能限制心肌梗死面积。

Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.

作者信息

Uraizee A, Reimer K A, Murry C E, Jennings R B

出版信息

Circulation. 1987 Jun;75(6):1237-48. doi: 10.1161/01.cir.75.6.1237.

DOI:10.1161/01.cir.75.6.1237
PMID:3568330
Abstract

Reactive oxygen species such as the superoxide anion (.O2-) have recently been implicated as important agents involved in causing cell death in the setting of myocardial ischemia and reperfusion. When superoxide anion is involved in ischemic injury the administration of superoxide dismutase (SOD) may limit infarct size by reducing the level of superoxide anions in the myocardium. The study described herein was done to determine whether SOD could limit myocardial infarct size when infarcts were produced in dogs by a 40 min occlusion of the circumflex coronary artery followed by 4 days of reperfusion. The animals in the SOD treatment group received a 1 hr intra-atrial infusion of SOD, at a rate of 250 U/kg/min starting 15 min after occlusion and ending 35 min after reperfusion; control dogs received a saline infusion over the same time frame. Infarct size was determined histologically and expressed as a percentage of the anatomic area at risk (AAR). Infarct size was similar in the two groups, averaging 26.2 +/- 2.5% in the control group (n = 10) and 21.1 +/- 4.8% in the SOD group (n = 11) (p = .40). Hemodynamic variables were not statistically different in the two groups during the occlusion. The transmural mean collateral blood flow at 10 min into the 40 min occlusion was 0.13 +/- 0.02 ml/min/g in the controls and 0.17 +/- 0.03 ml/min/g in the SOD group (p = NS); moreover, SOD did not alter collateral blood flow. In control dogs, infarct size was inversely related to collateral blood flow; analysis of covariance showed that SOD did not shift this relationship. Thus, SOD did not limit infarct size in this study. The results of the current study are consistent with our previous study in which allopurinol, a xanthine oxidase inhibitor, did not limit infarct size in this same experimental preparation. The results suggest that superoxide anions that are accessible to the infused SOD are not a major cause of myocyte death caused by 40 min of severe ischemia followed by reperfusion.

摘要

诸如超氧阴离子(·O₂⁻)等活性氧最近被认为是在心肌缺血和再灌注情况下导致细胞死亡的重要因素。当超氧阴离子参与缺血性损伤时,给予超氧化物歧化酶(SOD)可能通过降低心肌中超氧阴离子的水平来限制梗死面积。本文所述的研究旨在确定当通过闭塞左旋冠状动脉40分钟并随后再灌注4天在犬类中产生梗死时,SOD是否能够限制心肌梗死面积。SOD治疗组的动物在闭塞后15分钟开始,以250 U/kg/分钟的速率进行1小时的心房内SOD输注,再灌注后35分钟结束;对照犬在相同时间内接受生理盐水输注。通过组织学方法确定梗死面积,并表示为危险解剖区域(AAR)的百分比。两组的梗死面积相似,对照组(n = 10)平均为26.2±2.5%,SOD组(n = 11)平均为21.1±4.8%(p = 0.40)。在闭塞期间,两组的血流动力学变量无统计学差异。在40分钟闭塞开始10分钟时,对照组的透壁平均侧支血流为0.13±0.02 ml/分钟/克,SOD组为0.17±0.03 ml/分钟/克(p = 无显著性差异);此外,SOD并未改变侧支血流。在对照犬中,梗死面积与侧支血流呈负相关;协方差分析表明SOD并未改变这种关系。因此,在本研究中SOD并未限制梗死面积。当前研究的结果与我们之前的研究一致,在之前的研究中,黄嘌呤氧化酶抑制剂别嘌呤醇在相同的实验制剂中并未限制梗死面积。结果表明,注入的SOD可接触到的超氧阴离子并非由40分钟严重缺血后再灌注导致的心肌细胞死亡的主要原因。

相似文献

1
Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.犬缺血40分钟及再灌注4天后,超氧化物歧化酶未能限制心肌梗死面积。
Circulation. 1987 Jun;75(6):1237-48. doi: 10.1161/01.cir.75.6.1237.
2
Evidence against the "early protection-delayed death" hypothesis of superoxide dismutase therapy in experimental myocardial infarction. Polyethylene glycol-superoxide dismutase plus catalase does not limit myocardial infarct size in dogs.反对超氧化物歧化酶疗法在实验性心肌梗死中“早期保护-延迟死亡”假说的证据。聚乙二醇-超氧化物歧化酶加过氧化氢酶不能限制犬的心肌梗死面积。
Circ Res. 1990 Sep;67(3):636-44. doi: 10.1161/01.res.67.3.636.
3
Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.超氧化物歧化酶对犬心脏局部缺血及再灌注6小时后心肌梗死面积的影响:心肌挽救的验证
Circ Res. 1989 Apr;64(4):665-75. doi: 10.1161/01.res.64.4.665.
4
Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.重组人超氧化物歧化酶对实验性梗死面积的缩小作用:对再灌注损伤病理生理学的见解
Circulation. 1986 Dec;74(6):1424-33. doi: 10.1161/01.cir.74.6.1424.
5
Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs.
Circulation. 1988 Aug;78(2):473-80. doi: 10.1161/01.cir.78.2.473.
6
Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion.在阻断3小时后再灌注的清醒犬中,超氧化物歧化酶和过氧化氢酶未能改变梗死灶大小。
Circulation. 1986 May;73(5):1065-76. doi: 10.1161/01.cir.73.5.1065.
7
Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.与聚乙二醇结合的超氧化物歧化酶对犬心脏的心肌缺血/再灌注损伤提供持续保护。
Circ Res. 1988 Nov;63(5):944-59. doi: 10.1161/01.res.63.5.944.
8
Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: salvage or delay of myocyte necrosis?氧衍生自由基清除剂对冠状动脉永久性闭塞6小时后梗死面积的影响:挽救还是延迟心肌细胞坏死?
Basic Res Cardiol. 1987 Mar-Apr;82(2):146-58. doi: 10.1007/BF01907062.
9
Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs.
Circulation. 1985 May;71(5):1069-75. doi: 10.1161/01.cir.71.5.1069.
10
[Limitation of myocardial infarct size by polyethylene glycol-conjugated superoxide dismutase in a canine model of 90 min coronary occlusion followed by 4 days of reperfusion].聚乙二醇共轭超氧化物歧化酶对犬90分钟冠状动脉闭塞后再灌注4天模型中心肌梗死面积的限制作用
Kokyu To Junkan. 1989 Feb;37(2):201-8.

引用本文的文献

1
Ghrelin mediated cardioprotection using in vitro models of oxidative stress.利用氧化应激的体外模型进行 ghrelin 介导的心脏保护作用。
Gene Ther. 2024 Mar;31(3-4):165-174. doi: 10.1038/s41434-023-00435-9. Epub 2024 Jan 4.
2
Do reactive oxygen species damage or protect the heart in ischemia and reperfusion? Analysis on experimental and clinical data.活性氧在心肌缺血再灌注过程中对心脏是造成损伤还是起到保护作用?基于实验和临床数据的分析
J Biomed Res. 2023 Jul 28;37(4):268-280. doi: 10.7555/JBR.36.20220261.
3
Superoxide Dismutase-Loaded Nanoparticles Attenuate Myocardial Ischemia-Reperfusion Injury and Protect Against Chronic Adverse Ventricular Remodeling.
负载超氧化物歧化酶的纳米颗粒减轻心肌缺血再灌注损伤并预防慢性不良心室重构。
Adv Ther (Weinh). 2021 Jun;4(6). doi: 10.1002/adtp.202100036. Epub 2021 Apr 23.
4
Role of Mitochondrial Calcium and the Permeability Transition Pore in Regulating Cell Death.线粒体钙和通透性转换孔在调节细胞死亡中的作用。
Circ Res. 2020 Jan 17;126(2):280-293. doi: 10.1161/CIRCRESAHA.119.316306. Epub 2020 Jan 16.
5
Is Cardioprotection Dead?心脏保护作用已不复存在了吗?
Circulation. 2017 Jul 4;136(1):98-109. doi: 10.1161/CIRCULATIONAHA.116.027039.
6
Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment.急性心肌梗死中的细胞死亡机制:对治疗的病理生理学意义
Neth Heart J. 2001 Apr;9(1):30-44.
7
Rosuvastatin reduces ischemia-reperfusion injury in patients with acute coronary syndrome treated with percutaneous coronary intervention.瑞舒伐他汀可减轻接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的缺血再灌注损伤。
Clin Cardiol. 2014 Sep;37(9):530-5. doi: 10.1002/clc.22292. Epub 2014 Aug 25.
8
Delineating the relationships among the formation of reactive oxygen species, cell membrane instability and innate autoimmunity in intestinal reperfusion injury.阐明活性氧物质的形成、细胞膜不稳定性和肠道再灌注损伤中固有自身免疫之间的关系。
Mol Immunol. 2014 Apr;58(2):151-9. doi: 10.1016/j.molimm.2013.11.012. Epub 2013 Dec 22.
9
Loss of plasma membrane integrity, complement response and formation of reactive oxygen species during early myocardial ischemia/reperfusion.在心肌缺血/再灌注早期,细胞膜完整性丧失、补体反应和活性氧的形成。
Mol Immunol. 2013 Dec;56(4):507-12. doi: 10.1016/j.molimm.2013.05.001. Epub 2013 Aug 1.
10
Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.向心脏传递再生信号:微球和肽纳米纤维的心脏药物传递。
J Cardiovasc Transl Res. 2010 Oct;3(5):461-8. doi: 10.1007/s12265-010-9210-x. Epub 2010 Jul 14.